Largest Psychedelic Compound-Based Drug Stocks Up 14% MTD; Now Up 27% YTD

The psychedelic compound-based drug research and development sector is UP 13.6% MTD and is now UP 26.6% YTD and this article analyzes the performance of the 6 largest stocks in the Psychedelic Drug Stocks Index over those two time periods.